AN2 Therapeutics
intellectual property up to years of exclusivity united states japan patents issued in composition of matter patent expires june without hatch waxman extensions pediatric exclusivity up to years of extensions protection up to june orphan drug years gain act years available an therapeutics | AN2 Therapeutics
Company
Deck Type
Sector
Industry
Deck date
August 2022
Slide
21 of 25
Similar slides by AN2 Therapeutics
See diffirences between slides (animation)
IPO
March 2022
intellectual property up to years of exclusivity united states japan composition of matter patent expires june without hatch waxman extensions pediatric exclusivity up to years of extensions protection up to june regulatory exclusivity up to years post marketing orphan drug years gain act years patents issued in provides years of exclusivity from launch with as similar mechanisms available in japan an therapeutics | AN2 Therapeutics
Related slides by other companies
MindMed
Investor Day
June 2023
intellectual property in basics | MindMed
MAIA Biotechnology
Investor Presentation
October 2023
exclusivity and intellectual property | MAIA Biotechnology
Genelux
Investor Presentation
February 2024
intellectual property market exclusivity freedom to operate strong regulatory designations | Genelux
Genelux
Investor Presentation
July 2023
intellectual property market exclusivity freedom to operate strong regulatory designations a | Genelux
Other recent decks by AN2 Therapeutics
See all presentations (2 decks)
IPO
March 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io